TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized Controlled Trial of a Wellness Action Plan to Address the Childhood Obesity Epidemic
Brief Summary: The objective of this study was to determine the effectiveness of a novel Wellness Action Plan aimed at 1) improving parent recall of diet and activity plans 2) increasing follow-through with plans and 3) aiding parents in identifying their child's weight category.


Options:
A: Arm Label: A; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: School children and adolescents as health experts | Arm Label: B; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: School children and adolescents as health experts; Assigned to Arm(s): A
B: Intervention Type: BEHAVIORAL; Name: physical exercise; Assigned to Arm(s): N/A
C: Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Intervention group; Type: EXPERIMENTAL; Interventions: Behavioral: environmental and behavioral change | Intervention Type: BEHAVIORAL; Name: environmental and behavioral change; Assigned to Arm(s): Intervention group
D: Arm Label: Control Group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Wellness Plan; Type: EXPERIMENTAL; Interventions: Behavioral: Wellness Action Plan | Intervention Type: BEHAVIORAL; Name: Wellness Action Plan; Assigned to Arm(s): Wellness Plan

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Growth Hormone Co-treatment With the Microflare Stimulation Protocol in IVF/ICSI, Can it be a New Hope for Poor Responders?
Brief Summary: The effect of use of the microflare down regulation protocol on the outcome of the IVF/ICSI cycles in poor responders


Options:
A: Arm Label: Antagonist and Growth hormone; Type: EXPERIMENTAL; Interventions: Drug: Growth Hormone | Arm Label: Antagonist; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: Growth Hormone; Assigned to Arm(s): Antagonist and Growth hormone
B: Arm Label: The Long protocol; Type: EXPERIMENTAL; Interventions: Drug: Growth hormone (Norditropin, Novo nordisk) | Arm Label: The Short protocol; Type: EXPERIMENTAL; Interventions: Drug: Growth hormone (Norditropin, Novo nordisk) | Arm Label: The Antagonist protocol; Type: EXPERIMENTAL; Interventions: Drug: Growth hormone (Norditropin, Novo nordisk) | Arm Label: The Microflare protocol; Type: EXPERIMENTAL; Interventions: Drug: Growth hormone (Norditropin, Novo nordisk) | Intervention Type: DRUG; Name: Growth hormone (Norditropin, Novo nordisk); Assigned to Arm(s): The Antagonist protocol, The Long protocol, The Microflare protocol, The Short protocol
C: Arm Label: Long + Growth hormone; Type: ACTIVE_COMPARATOR; Interventions: Drug: Growth hormone | Arm Label: Long protocol only; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: Growth hormone; Assigned to Arm(s): Long + Growth hormone
D: Arm Label: Microflare and growth hormone; Type: EXPERIMENTAL; Interventions: Drug: Growth hormone (Norditropin, Novo nordisk) | Arm Label: Microflare protocol alone; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: Growth hormone (Norditropin, Novo nordisk); Assigned to Arm(s): Microflare and growth hormone

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: The improvement in inspiratory muscle function might result in beneficial changes in breathing pattern during whole body exercise. The hypothesis is the effect of inspiratory muscle training as an adjunct to a pulmonary rehabilitation program improves the breathing pattern during an incremental cycle exercise.


Options:
A: Intervention Type: OTHER; Name: inspiratory muscle training; Assigned to Arm(s): N/A
B: Intervention Type: PROCEDURE; Name: inspiratory muscle strength training; Assigned to Arm(s): N/A
C: Arm Label: Standard; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Inspiratory muscle training; Type: EXPERIMENTAL; Interventions: Other: Inspiratory muscle training | Intervention Type: OTHER; Name: Inspiratory muscle training; Assigned to Arm(s): Inspiratory muscle training
D: Arm Label: Inspiratory muscle training; Type: EXPERIMENTAL; Interventions: Procedure: Inspiratory muscle training | Intervention Type: PROCEDURE; Name: Inspiratory muscle training; Assigned to Arm(s): Inspiratory muscle training

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase II, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Brief Summary: The primary purpose of this study is to determine the efficacy and safety of KPI-121 0.25% ophthalmic suspension compared to vehicle (placebo) in subjects who have a documented clinical diagnosis of dry eye disease. The product will be studied over 28 days, with 1-2 drops instilled in each eye four times daily (QID).


Options:
A: Intervention Type: DRUG; Name: Lotemax; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Restasis; Assigned to Arm(s): N/A
B: Arm Label: Lotemax with warm compress group; Type: EXPERIMENTAL; Interventions: Drug: topical loteprednol etabonate (lotemax 0.5%) with warm compress & ocular massage | Arm Label: warm compress only group; Type: ACTIVE_COMPARATOR; Interventions: Other: warm compress only group | Intervention Type: DRUG; Name: topical loteprednol etabonate (lotemax 0.5%) with warm compress & ocular massage; Assigned to Arm(s): Lotemax with warm compress group | Intervention Type: OTHER; Name: warm compress only group; Assigned to Arm(s): warm compress only group
C: Arm Label: intense; Type: EXPERIMENTAL; Interventions: Drug: Softacort | Arm Label: standard; Type: EXPERIMENTAL; Interventions: Drug: Softacort | Intervention Type: DRUG; Name: Softacort; Assigned to Arm(s): intense, standard
D: Arm Label: KPI-121 0.25% Ophthalmic Suspension; Type: ACTIVE_COMPARATOR; Interventions: Drug: KPI-121 | Arm Label: Vehicle; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: KPI-121; Assigned to Arm(s): KPI-121 0.25% Ophthalmic Suspension | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Vehicle

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Efficacy and Impact of a Comprehensive Smoking Cessation Intervention During Radiation for Upper Aerodigestive Cancers
Brief Summary: Smoking is the greatest risk factor for upper aerodigestive cancers (thoracic or head and neck) and negatively impacts survival and other outcomes, but many patients have difficulty quitting after their diagnosis. Smoking cessation interventions for cancer patients thus far have had limited success. This is a pilot randomized controlled trial designed to determine if a new comprehensive, evidence-based smoking cessation intervention can improve quit rates for cancer patients who smoke.


Options:
A: Intervention Type: DRUG; Name: varenicline; Assigned to Arm(s): N/A
B: Arm Label: Comprehensive intervention; Type: EXPERIMENTAL; Interventions: Other: Comprehensive smoking cessation intervention | Arm Label: Enhanced usual care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Enhanced usual care | Intervention Type: OTHER; Name: Comprehensive smoking cessation intervention; Assigned to Arm(s): Comprehensive intervention | Intervention Type: BEHAVIORAL; Name: Enhanced usual care; Assigned to Arm(s): Enhanced usual care
C: Intervention Type: DRUG; Name: CP-526,555 (varenicline); Assigned to Arm(s): N/A
D: Arm Label: Placebo Control; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Smoking cessation counseling, Drug: Placebo | Arm Label: Experimental: Varenicline; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Smoking cessation counseling, Drug: Varenicline | Intervention Type: BEHAVIORAL; Name: Smoking cessation counseling; Assigned to Arm(s): Experimental: Varenicline, Placebo Control | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo Control | Intervention Type: DRUG; Name: Varenicline; Assigned to Arm(s): Experimental: Varenicline

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effects of Exercise Training in a Weight-loss Lifestyle Intervention on Clinical Control and Psychosocial Morbidity in Obese Asthmatics: a Randomized and Controlled Trial
Brief Summary: Obese asthmatics have more severe symptoms, reduced lung function, poorer quality of life and a reduced response to inhaled corticosteroid medication compared to non-obese asthmatics. In addition, the impact of a weight-loss program on clinical control and psychological outcomes has been poorly demonstrated and the effect of exercise training remain unknown. The investigators aim to investigate the effect of exercise training in a weight-loss program on asthma clinical control (primary outcome), health factors related to quality of life and psychosocial symptoms (secondary outcomes) in obese patients with moderate-to-severe persistent asthma. Physical activity, inflammatory profiles and sleep disorders will also be evaluated. The investigators' hypothesis is that exercise as part of a weight-loss program is more effective to lose weight and improve asthma control, quality of life and psychosocial symptoms in obese asthmatics.


Options:
A: Arm Label: Exercise, dietary and behavioral therapy; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Dietary, Behavioral: Education Program, Behavioral: Behavioral Therapy, Other: Exercise Training | Arm Label: Dietary and behavioral therapy; Type: SHAM_COMPARATOR; Interventions: Behavioral: Dietary, Behavioral: Education Program, Behavioral: Behavioral Therapy, Other: Stretching and Breathing exercise | Intervention Type: BEHAVIORAL; Name: Dietary; Assigned to Arm(s): Dietary and behavioral therapy, Exercise, dietary and behavioral therapy | Intervention Type: BEHAVIORAL; Name: Education Program; Assigned to Arm(s): Dietary and behavioral therapy, Exercise, dietary and behavioral therapy | Intervention Type: BEHAVIORAL; Name: Behavioral Therapy; Assigned to Arm(s): Dietary and behavioral therapy, Exercise, dietary and behavioral therapy | Intervention Type: OTHER; Name: Exercise Training; Assigned to Arm(s): Exercise, dietary and behavioral therapy | Intervention Type: OTHER; Name: Stretching and Breathing exercise; Assigned to Arm(s): Dietary and behavioral therapy
B: Arm Label: Aerobic exercise; Type: EXPERIMENTAL; Interventions: Behavioral: Aerobic exercise | Arm Label: Usual care; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Usual care | Intervention Type: BEHAVIORAL; Name: Aerobic exercise; Assigned to Arm(s): Aerobic exercise | Intervention Type: BEHAVIORAL; Name: Usual care; Assigned to Arm(s): Usual care
C: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Lifestyle intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Lifestyle intervention | Intervention Type: BEHAVIORAL; Name: Lifestyle intervention; Assigned to Arm(s): Lifestyle intervention
D: Arm Label: Patient cousenling; Type: OTHER; Interventions: Other: Aerobic training | Intervention Type: OTHER; Name: Aerobic training; Assigned to Arm(s): Patient cousenling

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Making Ramadhan Fasting a Safer Experience With Technology Study
Brief Summary: Type 2 diabetes mellitus (T2DM) is a chronic condition that is one of the major causes of illness, disability, and death in Malaysia with an increasing prevalence. Despite the best effort, only 1 in 3 patients ever meet their HbA1c goal. In most patients with type 2 diabetes, the use of oral anti-diabetics is a mainstay in therapy. However, there is a risk of hypoglycaemia in most patients taking these drugs. This is especially important in T2DM Muslims wishing to fast during Ramadan as the dietary pattern changes to one large meal at sunset called 'Iftaar' and a light meal before dawn called 'Sahur'. Most Muslims will generally consume large quantities of fried and sugary foods when they break their fast or during the night. Given the importance and public health significance of poor diabetes management and its associated risk especially during Ramadan, the investigators aim to test the intervention of using remote monitoring within community provider practice for patients with T2DM. The investigators hypothesize that the combined use of a mobile enable glucometer which can directly feedback the patients glycaemic levels to the physicians will reduce and even eliminate the occurrence of hypoglycaemia whilst ensuring that patients remain euglycaemic throughout the whole Ramadan month.


Options:
A: Arm Label: Internet Intervention; Type: EXPERIMENTAL; Interventions: Other: Internet Intervention | Arm Label: Standard Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Internet Intervention; Assigned to Arm(s): Internet Intervention
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Expanded Chronic Care Model | Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Expanded Chronic Care Model; Assigned to Arm(s): 1
C: Arm Label: Active Control Group (ACG); Type: OTHER; Interventions: Device: Accu-Chek Aviva Glucose Meter | Arm Label: Structured Testing Group (STG); Type: EXPERIMENTAL; Interventions: Device: Accu-Chek 360° View Blood Glucose Analysis Tool, Device: Accu-Chek Aviva Glucose Meter | Intervention Type: DEVICE; Name: Accu-Chek 360° View Blood Glucose Analysis Tool; Assigned to Arm(s): Structured Testing Group (STG) | Intervention Type: DEVICE; Name: Accu-Chek Aviva Glucose Meter; Assigned to Arm(s): Active Control Group (ACG), Structured Testing Group (STG)
D: Arm Label: Usual care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Telemedicine; Type: EXPERIMENTAL; Interventions: Device: Telemedicine | Intervention Type: DEVICE; Name: Telemedicine; Assigned to Arm(s): Telemedicine

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Keeping Weight Off: Brain Changes Associated With Healthy Behaviors
Brief Summary: The goal of this project is to characterize changes in emotion regulation pathways associated with healthy behaviors in people who have recently lost weight and are seeking to maintain weight loss over a 1-year period.


Options:
A: Intervention Type: BEHAVIORAL; Name: Mindfulness Based Stress Reduction; Assigned to Arm(s): N/A
B: Arm Label: MBCT; Type: EXPERIMENTAL; Interventions: Behavioral: Mindfulness-Based Cognitive Therapy (MBCT) | Arm Label: CBT; Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive Behavioral Therapy (CBT) | Arm Label: Waitlist; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Mindfulness-Based Cognitive Therapy (MBCT); Assigned to Arm(s): MBCT | Intervention Type: BEHAVIORAL; Name: Cognitive Behavioral Therapy (CBT); Assigned to Arm(s): CBT
C: Arm Label: Mindfulness Based Stress Reduction (MBSR) program; Type: EXPERIMENTAL; Interventions: Behavioral: Mindfulness | Arm Label: Healthy Living Course (HLC); Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Psychoeducation | Intervention Type: BEHAVIORAL; Name: Mindfulness; Assigned to Arm(s): Mindfulness Based Stress Reduction (MBSR) program | Intervention Type: BEHAVIORAL; Name: Psychoeducation; Assigned to Arm(s): Healthy Living Course (HLC)
D: Arm Label: Experimental; Type: EXPERIMENTAL; Interventions: Behavioral: Mindful Eating | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Mindful Eating; Assigned to Arm(s): Experimental

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effect of Platelet Rich Plasma ( PRP ) Applied During Knee Arthroscopy on Pain, Function and Quality of Life - A RCT With a Follow up of 12 Months
Brief Summary: The purpose of this study is to investigate reduction of pain, gain of function and improvement of life quality by intraoperative applied platelet- rich- plasma ( PRP ) during knee arthroscopy for degeneration and osteoarthritis OA by conducting a randomized- controlled, double-blinded trial ( RCT ) including 58 patients with a follow up of 12 months and pain, assessed by Visual- Analogue Scale (VAS) after 6 months as primary endpoint.


Options:
A: Arm Label: APM group; Type: EXPERIMENTAL; Interventions: Procedure: Arthroscopic partial meniscectomy | Arm Label: Sham group; Type: PLACEBO_COMPARATOR; Interventions: Procedure: Sham procedure | Intervention Type: PROCEDURE; Name: Arthroscopic partial meniscectomy; Assigned to Arm(s): APM group | Intervention Type: PROCEDURE; Name: Sham procedure; Assigned to Arm(s): Sham group
B: Arm Label: Arthroscopy plus Medical Management; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Arthroscopy plus Medical Management, Other: Medical Management | Arm Label: Medical Management; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: Arthroscopy plus Medical Management; Assigned to Arm(s): Arthroscopy plus Medical Management | Intervention Type: OTHER; Name: Medical Management; Assigned to Arm(s): Arthroscopy plus Medical Management
C: Arm Label: Operative (O); Type: ACTIVE_COMPARATOR; Interventions: Procedure: Operative (partial arthroscopy) | Arm Label: Conservative (K); Type: SHAM_COMPARATOR; Interventions: Procedure: Conservative (diagnostic arthroscopy) | Intervention Type: PROCEDURE; Name: Operative (partial arthroscopy); Assigned to Arm(s): Operative (O) | Intervention Type: PROCEDURE; Name: Conservative (diagnostic arthroscopy); Assigned to Arm(s): Conservative (K)
D: Arm Label: PRP; Type: EXPERIMENTAL; Interventions: Biological: Platelet rich plasma | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BIOLOGICAL; Name: Platelet rich plasma; Assigned to Arm(s): PRP

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Botswana Vitamin D Supplementation Study in HIV/AIDS
Brief Summary: The goal is to determine the vit D supplementation dose that safely results in optimal serum vitamin D (25D) concentrations in HIV-infected children and adults living in Botswana. To do this the investigators will test two oral daily doses (4000 vs. 7000 IU) of cholecalciferol (D3) dietary supplement over a 12-week period in 60 children and adults with HIV/AIDS living in Botswana (5.0 to 50.9 yrs), to assess safety as determined by serum calcium and 25D concentrations and efficacy to replete vit D status as determined by achieving a minimum serum 25D concentration of 32 ng/mL (80 nmol/L).


Options:
A: Arm Label: Selenium; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Selenium | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Intervention Type: DIETARY_SUPPLEMENT; Name: Selenium; Assigned to Arm(s): Selenium | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: 4000 IU/d of D3 by mouth for 12 weeks; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: 4000 IU/d D3 over 12 weeks | Arm Label: 7000IU/d of D3 by mouth for 12 weeks; Type: EXPERIMENTAL; Interventions: Dietary Supplement: 7000 IU/d D3 over 12 weeks | Intervention Type: DIETARY_SUPPLEMENT; Name: 4000 IU/d D3 over 12 weeks; Assigned to Arm(s): 4000 IU/d of D3 by mouth for 12 weeks | Intervention Type: DIETARY_SUPPLEMENT; Name: 7000 IU/d D3 over 12 weeks; Assigned to Arm(s): 7000IU/d of D3 by mouth for 12 weeks
C: Arm Label: 1; Type: PLACEBO_COMPARATOR; Interventions: Drug: No supplementation | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Vitamin D | Arm Label: 3; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Vitamin D | Intervention Type: DIETARY_SUPPLEMENT; Name: Vitamin D; Assigned to Arm(s): 2 | Intervention Type: DRUG; Name: No supplementation; Assigned to Arm(s): 1 | Intervention Type: DIETARY_SUPPLEMENT; Name: Vitamin D; Assigned to Arm(s): 3
D: Intervention Type: DRUG; Name: multivitamin; Assigned to Arm(s): N/A

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Wii-Fit For Balance And Gait In Elderly Veterans
Brief Summary: Falls are a major public health problem. They are the leading cause of injuries and injury-related deaths in those aged over 65 years. Balance and gait abnormalities are major reasons for falls in elderly. Exercise interventions improve gait and balance in the elderly. Despite the many proven benefits of exercise, many older adults in the US remain sedentary. This study targets at improving balance and gait with use of Wii-Fit as an exercise program.


Options:
A: Arm Label: TT+VR; Type: EXPERIMENTAL; Interventions: Other: TT+VR | Arm Label: TT alone; Type: ACTIVE_COMPARATOR; Interventions: Other: TT alone | Intervention Type: OTHER; Name: TT+VR; Assigned to Arm(s): TT+VR | Intervention Type: OTHER; Name: TT alone; Assigned to Arm(s): TT alone
B: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Device: Exergame device | Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Device: Exergame device | Intervention Type: DEVICE; Name: Exergame device; Assigned to Arm(s): Control, Intervention
C: Arm Label: Wii-Fit program; Type: EXPERIMENTAL; Interventions: Other: Wii-Fit exercises | Arm Label: Cognitive remediation program; Type: PLACEBO_COMPARATOR; Interventions: Other: Cognitive remediation exercises | Intervention Type: OTHER; Name: Wii-Fit exercises; Assigned to Arm(s): Wii-Fit program | Intervention Type: OTHER; Name: Cognitive remediation exercises; Assigned to Arm(s): Cognitive remediation program
D: Arm Label: Exergame; Type: EXPERIMENTAL; Interventions: Behavioral: Exergame | Arm Label: Usual Care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Usual Care | Intervention Type: BEHAVIORAL; Name: Exergame; Assigned to Arm(s): Exergame | Intervention Type: BEHAVIORAL; Name: Usual Care; Assigned to Arm(s): Usual Care

Answer: C